CCT018159 is an ATP-competitive HSP90beta inhibitor, with an IC50 of 3.2 µM against human HSP90beta ATPase and 6.6 µM against yeast HSP90beta ATPase. CCT018159 induces cell cycle arrest and apoptosis in tumor cells, and inhibits invasion and angiogenesis. CCT018159 is applicable to cancer-related research[1][2].
Molecular Weight:
352.38
Purity:
99.30
CAS Number:
[171009-07-7]
Formula:
C20H20N2O4
Target:
Apoptosis,CDK,HSP,PERK
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
